Tirzepatide works by activating GIP and GLP-1 receptors, which enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, slow gastric emptying, and reduce appetite through central nervous system pathways
It also intersects the energetic substrate upon which dopaminergic neurons depend
The efficiency of the drug in controlling the blood glucose levels, coupled with their added advantages of fostering weight loss and lowering the risks of cardiovascular diseases, is significantly contributing to the rising GLP-1 receptor agonist market revenue
CJC-1295 is a growth hormone releasing hormone (GHRH) analog designed to support prolonged growth hormone activity
It protects the cell membranes against lipid peroxidation chain reaction by reacting with the lipid radicals produced due to OS
Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes
